JP7408539B2 - プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物 - Google Patents

プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物 Download PDF

Info

Publication number
JP7408539B2
JP7408539B2 JP2020509216A JP2020509216A JP7408539B2 JP 7408539 B2 JP7408539 B2 JP 7408539B2 JP 2020509216 A JP2020509216 A JP 2020509216A JP 2020509216 A JP2020509216 A JP 2020509216A JP 7408539 B2 JP7408539 B2 JP 7408539B2
Authority
JP
Japan
Prior art keywords
composition
reducing
body fat
bifidobacterium
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020509216A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019189408A1 (ja
Inventor
淳一 南
旭 宣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of JPWO2019189408A1 publication Critical patent/JPWO2019189408A1/ja
Priority to JP2023214019A priority Critical patent/JP2024026410A/ja
Application granted granted Critical
Publication of JP7408539B2 publication Critical patent/JP7408539B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Polymers & Plastics (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
JP2020509216A 2018-03-29 2019-03-27 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物 Active JP7408539B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023214019A JP2024026410A (ja) 2018-03-29 2023-12-19 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018064982 2018-03-29
JP2018064982 2018-03-29
PCT/JP2019/013272 WO2019189408A1 (ja) 2018-03-29 2019-03-27 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023214019A Division JP2024026410A (ja) 2018-03-29 2023-12-19 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物

Publications (2)

Publication Number Publication Date
JPWO2019189408A1 JPWO2019189408A1 (ja) 2021-03-18
JP7408539B2 true JP7408539B2 (ja) 2024-01-05

Family

ID=68059033

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020509216A Active JP7408539B2 (ja) 2018-03-29 2019-03-27 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物
JP2023214019A Pending JP2024026410A (ja) 2018-03-29 2023-12-19 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023214019A Pending JP2024026410A (ja) 2018-03-29 2023-12-19 プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物

Country Status (4)

Country Link
US (1) US12059442B2 (https=)
JP (2) JP7408539B2 (https=)
TW (1) TWI844535B (https=)
WO (1) WO2019189408A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7556881B2 (ja) * 2019-04-17 2024-09-26 バイオガイア エイビー プロバイオティック細菌の治療用マイクロベシクル
WO2021107500A1 (ko) 2019-11-29 2021-06-03 주식회사 지니스 혈중 암모니아 수치 저하능을 갖는 균주 및 이를 포함하는 신경세포 보호용 조성물
US20210237064A1 (en) * 2020-01-31 2021-08-05 Astrin Biosciences, Inc. Biological Fluid Filtration System
CA3205469A1 (en) * 2020-12-18 2022-06-23 The General Hospital Corporation Probiotics compositions and method of using the same to enhance growth and social function in children
JP7113550B1 (ja) * 2021-05-11 2022-08-05 株式会社アルソア慧央グループ 抗鬱剤、抗老化剤及び抗肥満剤
JP7549407B2 (ja) * 2021-12-23 2024-09-11 株式会社メタジェン 情報提供システム
CN115300605A (zh) * 2022-08-16 2022-11-08 比菲德(北京)生物科技有限公司 一种用于抗肥胖、瘦身的益生菌粉及其应用
EP4673156A1 (en) * 2023-02-28 2026-01-07 University Of South Florida Method of making a probiotic fermented product
IT202300021603A1 (it) * 2023-10-17 2025-04-17 Noos S R L Nuova composizione a base di probiotici

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011034166A1 (ja) 2009-09-17 2011-03-24 森永乳業株式会社 抗肥満剤、抗肥満用飲食品、耐糖能改善剤及び耐糖能改善用飲食品
CN107684567A (zh) 2017-11-07 2018-02-13 大连医科大学 一种用于改善肥胖和降低血脂的复合益生菌制剂
CN107760620A (zh) 2017-10-18 2018-03-06 天津科睿恒生物科技有限公司 一株改善易胖体质及子代体重的植物乳杆菌及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010285425A (ja) 2009-05-12 2010-12-24 Fujifilm Corp 腸内細菌叢構成比率調整剤
JP7244977B2 (ja) * 2016-03-11 2023-03-23 シオノギヘルスケア株式会社 腸内細菌叢調整用組成物
AU2017318650B2 (en) * 2016-09-02 2021-12-09 Société des Produits Nestlé S.A. Compositions and methods for modulating gastrointestinal microflora in a canine
CN107125767B (zh) * 2017-04-28 2020-09-29 黑龙江大学 一种短双歧杆菌、发酵乳杆菌和植物乳杆菌三菌复合微粒子的制备方法及应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011034166A1 (ja) 2009-09-17 2011-03-24 森永乳業株式会社 抗肥満剤、抗肥満用飲食品、耐糖能改善剤及び耐糖能改善用飲食品
CN107760620A (zh) 2017-10-18 2018-03-06 天津科睿恒生物科技有限公司 一株改善易胖体质及子代体重的植物乳杆菌及应用
CN107684567A (zh) 2017-11-07 2018-02-13 大连医科大学 一种用于改善肥胖和降低血脂的复合益生菌制剂

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Dig. Dis., (2016), 34, [3], p.221-229
Obesity, (2013), 21, [12], p.E607-E615
食品工業, (2012), 55, [4], p.54-58

Also Published As

Publication number Publication date
JP2024026410A (ja) 2024-02-28
US12059442B2 (en) 2024-08-13
TW201944906A (zh) 2019-12-01
US20210196767A1 (en) 2021-07-01
WO2019189408A1 (ja) 2019-10-03
JPWO2019189408A1 (ja) 2021-03-18
TWI844535B (zh) 2024-06-11

Similar Documents

Publication Publication Date Title
JP7408539B2 (ja) プロバイオティクスを用いた肥満の治療、体脂肪減少用組成物、及びウエスト周囲径低減用組成物
AU2019243093B2 (en) Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition
JP7280069B2 (ja) 機能性消化管障害予防又は改善用組成物、並びに、該機能性消化管障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物
JPWO2019117212A1 (ja) ビフィドバクテリウム属細菌を有効成分とする組成物
JP7261867B2 (ja) 骨格筋遅筋化用組成物
JP2019116423A (ja) 整腸用組成物
JP2024049199A (ja) プラズマサイトイド樹状細胞活性化用組成物
JP2021155349A (ja) 腸内細菌叢改善用組成物
WO2024101341A1 (ja) 新生児又は乳幼児のための組成物
JP7368484B2 (ja) 組成物並びに該組成物含有する飲食品組成物および調製乳
JP7299744B2 (ja) 血中尿酸値低減用組成物、及び高尿酸血症予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP7475155B2 (ja) 持久力向上用組成物
JP2024031727A (ja) プラズマサイトイド樹状細胞活性化用組成物
JP7333732B2 (ja) 筋肉量及び／又は筋力の維持、或いは筋肉量及び／又は筋力の低下抑制用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP7326075B2 (ja) 腎機能障害の予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP7591364B2 (ja) 健康寿命延長用組成物
WO2020251044A1 (ja) ビフィドバクテリウム属細菌を有効成分とする組成物
JP7696423B2 (ja) 組成物
JP7309436B2 (ja) 腎機能障害予防又は改善用組成物、並びに、該腎機能障害予防又は改善用組成物を用いた医薬品組成物及び飲食品組成物
JP2026011440A (ja) 労働パフォーマンスの向上用組成物
JP2021042143A (ja) 脂質代謝異常及び／又は糖代謝異常の予防又は改善用組成物、並びに、該組成物を用いた医薬品組成物及び飲食品組成物
JP2022156305A (ja) エリスロポエチン産生促進用組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230801

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231121

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231220

R150 Certificate of patent or registration of utility model

Ref document number: 7408539

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350